ES2083458T3 - Composicion antivirica. - Google Patents

Composicion antivirica.

Info

Publication number
ES2083458T3
ES2083458T3 ES90911382T ES90911382T ES2083458T3 ES 2083458 T3 ES2083458 T3 ES 2083458T3 ES 90911382 T ES90911382 T ES 90911382T ES 90911382 T ES90911382 T ES 90911382T ES 2083458 T3 ES2083458 T3 ES 2083458T3
Authority
ES
Spain
Prior art keywords
composition
ethyluracil
diaminopurine
inosine
thymine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911382T
Other languages
English (en)
Inventor
Bo Oberg
Britta Wahren
Johan Harmenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2083458T3 publication Critical patent/ES2083458T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA COMPOSICION TERAPEUTICA QUE COMPRENDE UNA COMBINACION DE UN COMPUESTO 3''-FLUOR-2'',3''-DIDEOXI-NUCLEOSIDO (I) DE LA FORMULA (I), DONDE B ES ADENINA, TIMINA, GUANINA, CITOSINA, INOSINA, URACIL, 5-ETILURACIL, 2,6 -DIAMINOPURINA; Y UN COMPUESTO 2'',3''-DIDEOXINUCLEOSIDO (II) DE LA FORMULA (II), DONDE X ES N SUB 3 O H O JUNTO CON Y UNA UNION ADICIONAL CARBONO-CARBONO, Y Y Z SON INDEPENDIENTEMENTE H, OH O F, Y B ES ADENINA, TIMINA, GUANINA, CITOSINA, INOSINA, URACIL, 5-ETILURACIL, 2,6-DIAMINOPURINA , EN UNA RAZON QUE DA UN EFECTO ANTIVIRAL SINERGISTICO. LA COMPOSICION SE PUEDE UTILIZAR EN EL TRATAMIENTO O PROFILAXIS DE INFECCIONES CAUSADAS POR VIRUS UTILIZANDO TRANSCRIPTASA INVERSA PARA LA REPLICA, ESPECIALMENTE INFECCIONES DE VIH Y SIDA.
ES90911382T 1989-07-19 1990-07-10 Composicion antivirica. Expired - Lifetime ES2083458T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902568A SE464168B (sv) 1989-07-19 1989-07-19 Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)

Publications (1)

Publication Number Publication Date
ES2083458T3 true ES2083458T3 (es) 1996-04-16

Family

ID=20376569

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911382T Expired - Lifetime ES2083458T3 (es) 1989-07-19 1990-07-10 Composicion antivirica.

Country Status (11)

Country Link
US (1) US5571798A (es)
EP (1) EP0482081B1 (es)
JP (1) JP3149179B2 (es)
AT (1) ATE132752T1 (es)
AU (1) AU630220B2 (es)
CA (1) CA2063417C (es)
DE (1) DE69024804T2 (es)
DK (1) DK0482081T3 (es)
ES (1) ES2083458T3 (es)
SE (1) SE464168B (es)
WO (1) WO1991001137A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088443T3 (es) * 1990-08-06 1996-08-16 American Cyanamid Co Procedimiento para la preparacion de desoxinucleosidos.
EP0555302A1 (en) * 1990-10-30 1993-08-18 The Wellcome Foundation Limited Method of treating demyelinating disease
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
CZ285232B6 (cs) † 1991-05-16 1999-06-16 Glaxo Group Limited Protivirové směsi
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
GB9226927D0 (en) * 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues
US5760013A (en) * 1996-08-21 1998-06-02 National Science Council Thymidylate analogs and the use thereof
US5841975A (en) * 1996-12-10 1998-11-24 The Regents Of The University Of California Method and apparatus for globally-accessible automated testing
US5968731A (en) * 1996-12-10 1999-10-19 The Regents Of The University Of California Apparatus for automated testing of biological specimens
US5925514A (en) * 1996-12-10 1999-07-20 The Regents Of The University Of California Apparatus for testing for infection by a retrovirus
DE19832519A1 (de) * 1998-07-20 2000-01-27 Hartmut Oswald Arzneimittelzubereitungen zur topischen Behandlung mukokutaner Herpesinfektionen sowie der Keratitis herpetica des Auges
US7534605B2 (en) * 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
WO2004002433A1 (en) * 2002-06-27 2004-01-08 Medivir Ab Synergistic interaction of abacavir and alovudine
EP1610782A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
WO2004087139A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of tipranavir and a further antiretroviral compound
WO2004087169A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of nevirapine and a further antiretroviral compound
NZ597544A (en) * 2005-09-26 2013-04-26 Gilead Pharmasset Llc Modified 4'-nucleosides as antiviral agents
GB0608876D0 (en) 2006-05-05 2006-06-14 Medivir Ab Combination therapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US4879277A (en) * 1985-08-26 1989-11-07 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions and methods
JPS62501712A (ja) * 1985-08-26 1987-07-09 アメリカ合衆国 ２′、３′―ジデオキシイノシン、２′，３′―ジデオキシグアノシンまたは２′，３′―ジデオキシアデノシンを含有する抗ｈｔｌｖ―３／ｌａｖ剤
US4681933A (en) * 1986-05-01 1987-07-21 University Of Georgia Research Foundation, Inc. 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
EP0286825A3 (en) * 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US4904770A (en) * 1988-03-24 1990-02-27 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
US5059418A (en) * 1989-09-20 1991-10-22 The Administrators Of The Tulane Educational Fund Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
US5026687A (en) * 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination

Also Published As

Publication number Publication date
SE8902568D0 (sv) 1989-07-19
ATE132752T1 (de) 1996-01-15
AU630220B2 (en) 1992-10-22
DE69024804T2 (de) 1996-08-29
AU6046990A (en) 1991-02-22
EP0482081B1 (en) 1996-01-10
SE8902568L (sv) 1991-01-20
US5571798A (en) 1996-11-05
EP0482081A1 (en) 1992-04-29
JPH04506961A (ja) 1992-12-03
CA2063417C (en) 2000-12-12
CA2063417A1 (en) 1991-01-20
DK0482081T3 (da) 1996-05-28
JP3149179B2 (ja) 2001-03-26
SE464168B (sv) 1991-03-18
WO1991001137A1 (en) 1991-02-07
DE69024804D1 (de) 1996-02-22

Similar Documents

Publication Publication Date Title
ATE132752T1 (de) Antivirale zusammensetzung
GR3020064T3 (en) 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates
DE3751947T2 (de) Nucleosidderivate und ihre Verwendung in der Oligonucleotid-Synthese
ATE314077T1 (de) 5-fluoro-2',3'-ungesättigte pyrimidinnucleoside
CA2053339A1 (en) Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
EP0398231A3 (en) Nucleoside analogs
CA2054870A1 (en) Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
FI932868A0 (fi) 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
DK0720604T3 (da) Konformationelt låste nukleosidanaloger
DK630589A (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
DE3854811T2 (de) Anti-HIV Pyrimidin Nucleoside
EP0034424A3 (en) Seven-membered ring compounds as inhibitors of cytidine deaminase
IL80004A0 (en) 7-aminoazolo(1,5-a)pyrimidines and their use as fungicides
NO891835D0 (no) Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider.
GB9506644D0 (en) Preparation of nucleoside analogues
KR960701639A (ko) 심기능 회복제(heart function restorative)
EP0381533A3 (en) Cyclic monophosphates of purine and pyrimidine acyclonucleosides
JPS6426594A (en) Nucleotides and antitumor agent
ES2002342A6 (es) Procedimiento para la preparacion de 3'-azido-nucleosidos
EP0544668A4 (en) 6-HALO- AND 2-AMINO-6-HALO-PURINE 2 ', 3'-DIDESOXY NUCLEOSIDES AND THEIR USE AS ANTIVIRAL AGENTS.
ZA907938B (en) Further antiviral pyrimidine nucleosides
IE821856L (en) 5-(2-halogenovinyl) -2' -deoxyuridine antiviral agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 482081

Country of ref document: ES